DPP4-Inhibitors and Bone Metabolism in Diabetes

NCT06770894 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Bone Loss, Postmenopausal
Diabetes Mellitus Type 2

Interventions

DRUG: Sitagliptin 100 mg
DRUG: Placebo Tablets

Sponsor

Azienda Policlinico Umberto I

Collaborators

[object Object]